First Autonomous Blood-Draw Robot Gets FDA Authorization
The U.S. Food and Drug Administration has given the green light to Aletta, a groundbreaking robotic system capable of performing blood draws entirely on its own...
Jubilant Ingrevia Enters Electronics Sector with ₹189.2 Crore Stake in Zettaone Technologies
Jubilant Ingrevia Limited has announced a strategic move to diversify its business portfolio by acquiring a 40% equity stake in Zettaone Technologies for ₹189.2 crore.
The strategic investment marks...
Union Health Ministry Proposes Inclusion of Four Drugs Under Schedule H1 to Tighten Regulatory Oversight
The Ministry of Health and Family Welfare (MoHFW), Department of Health and Family Welfare, has issued a draft gazette notification (G.S.R. 745(E)) proposing the...
Amylyx Pharmaceuticals Announces Positive Phase 3 Trial Results for Avexitide, for Post-Bariatric Hypoglycemia
Amylyx Pharmaceuticals has announced positive top-line results from its pivotal Phase 3 LUCIDITY trial evaluating avexitide, a first-in-class glucagon-like peptide-1 (GLP-1) receptor antagonist being...
Merck & Moderna’s Personalized mRNA Cancer Vaccine Succeeds in Phase 3 Melanoma Trial
Pharmaceutical giants Merck and Modernarevealed encouraging results from their Phase 3 INTerpath-001 study, testing an individualized mRNA cancer vaccine alongside Merck's immunotherapy drug Keytruda in melanoma patients.
The...
Glenmark Secures U.S. FDA Approval for Flonase®️ Nasal Spray
Glenmark Pharmaceuticals Limited has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluticasone Propionate...
